Xerostomia (Dry Mouth) Market

Global Xerostomia (Dry Mouth) Market, Size, Share and Trend Analysis Report By Product Type (Artificial Saliva, Dentifrices, Salivary Stimulants, Saliva Substitutes, Salivary Pen), By Type (Prescribed Drugs, OTC Drugs), Forecast Period (2020-2027)

Published: Dec 2021 | Report Code: OMR2025072 | Category : Pharmaceuticals | Delivery Format: /

The global Xerostomia (dry mouth) market is anticipated to grow at a significant CAGR during the forecast period. The rising prevalence of Sjogren’s syndrome, where the immune cells of the body target the news cells which have salivary and tear glands is the major factor that is driving the global Xerostomia (dry mouth) market during the forecast period. 

People suffering from this disease have a history of diseases like Sjogren’s syndrome or have undergone radiation therapy for head and neck cancer. According to NCBI, currently, around 15-20 million people are suffering from this disease. There has been an increase in the growing awareness regarding this disease and the other ailments associated with it. 

Furthermore, with the increasing number of cancer chemotherapy, the risk of Xerostomia is also increasing as chemotherapy might lead to having thick saliva causing dry mouth which is driving the growth of the market. Some of the key global market players include GlaxoSmithKline Plc, Church & Dwight Co., Inc., Colgate-Palmolive Co., Sun Pharmaceuticals Industries Ltd., Lupin Pharmaceuticals, Inc., Pfizer, Inc., Parnell Pharmaceuticals, Inc., Acacia Pharma Group Plc, Quest Products, LLC (OraCoat), EUSA Pharma NP, and many others.

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered- 

o By Product Type

o By Type

  • Competitive Landscape - GlaxoSmithKline Plc, Church & Dwight Co., Inc., Colgate-Palmolive Co., Sun Pharmaceuticals Industries Ltd., Lupin Pharmaceuticals, Inc. and many others.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Xerostomia (Dry Mouth) Market by Segment

By Product Type

o Artificial Saliva

o Dentifrices

o Salivary Stimulants

o Saliva Substitutes

o Salivary Pen

By Application

o Prescribed Drugs

o OTC Drugs

Global Xerostomia (Dry Mouth) Market by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World